SP
Sunny Prafulbhai Shah
About Sunny Prafulbhai Shah
Data last updated:
Sunny Prafulbhai Shah is a Director at Chemist180 Epharmacy Private Limited (since 2019) and Director at Nuciphar Healthcare Private Limited (since 2023). The companies operate in Home Appliances. The largest current company by reported revenue is Chemist180 Epharmacy Private Limited at ₹66.1 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 31 Dec 2019 | 2019 | ₹66.1 Lakh (FY 2024) | Active | |
| Director | 09 Aug 2023 | 2023 | Active |
Board colleagues of Sunny Prafulbhai Shah
| Name | DIN | Company | Designation |
|---|---|---|---|
| Prafulkumar Jethalal Shah | 08654865 | Chemist180 Epharmacy Private Limited | Director |
| Sagar Anilkumar Patel | 08395717 | Nuciphar Healthcare Private Limited | Director |
| Vishrut Dineshkumar Shah | 10273020 | Nuciphar Healthcare Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sunny Prafulbhai Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sunny Prafulbhai Shah
Sunny Prafulbhai Shah currently holds 2 directorships: Chemist180 Epharmacy Private Limited (Director, since 31 Dec 2019, revenue ₹66.1 Lakh (FY 2024)); Nuciphar Healthcare Private Limited (Director, since 09 Aug 2023).
Sunny Prafulbhai Shah was first appointed on 31 Dec 2019 as Director at Chemist180 Epharmacy Private Limited. The most recent appointment on record is 09 Aug 2023 at Nuciphar Healthcare Private Limited.
The current boards of Sunny Prafulbhai Shah's companies include Prafulkumar Jethalal Shah (Chemist180 Epharmacy Private Limited), Sagar Anilkumar Patel (Nuciphar Healthcare Private Limited), Vishrut Dineshkumar Shah (Nuciphar Healthcare Private Limited).